The influence of the metabolic phenotype of CD8+T cells on immunotherapy response in patients with non-small cell lung cancer (NSCLC)

被引：0

作者：

Tan, Sze Ying ^{[1
]}

Kearney, Ella ^{[2
]}

Flanagan, Saoirse ^{[1
,3
]}

O'Reilly, David ^{[4
]}

Naidoo, Jarushka ^{[4
]}

Dowling, Catriona ^{[1
]}

机构：

[1] Royal Coll Surgeons Ireland, Dublin, Ireland

[2] Trinity Coll Dublin, Dublin, Ireland

[3] Univ Limerick, Limerick, Ireland

[4] Beaumont Hosp, Dublin, Ireland

来源：

EUROPEAN JOURNAL OF IMMUNOLOGY | 2024年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

2048 - P1.

引用

页码：788 / 788

页数：1

共 50 条

[21] Patterns of Response to Nivolumab in Patients with Non-Small Cell Lung Cancer (NSCLC)
Schmid, S.
Diem, S.
Krapf, M.
Li, Q.
Flatz, L.
Leschka, S.
Desbiolles, L.
Klingbiel, D.
Jochum, W.
Fruh, M.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2420
[22] Clinical Predictive Markers of Response to Immunotherapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
Rhone, R.
Raez, L.
Dumais, K.
Powery, H.
Gentile, F.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S1083 - S1083
[23] Clinical relevance of immune factors beyond CD8+T cells and mutation status of EGFR and ALK in patients with non-small cell lung cancer
Wang, K.
Zhang, H.
Wang, X.
Liu, Y.
Duan, J.
Lei, Y.
She, X.
Shen, X.
Huang, D.
ANNALS OF ONCOLOGY, 2020, 31 : S809 - S809
[24] Rutecarpine Suppresses Non-Small Cell Lung Cancer Progression Through Activating the STING Pathway and Elevating CD8+T Cells
Jiang, Ze-Bo
He, Qing-Hua
Kang, Li-Ping
Jiang, Sha
Liu, Jia-Ni
Xu, Cong
Wang, Wen-Jun
Wang, Xuan-Run
Wu, Qi-Biao
Huang, Dong-Hui
CHEMICAL BIOLOGY & DRUG DESIGN, 2025, 105 (02)
[25] Differential predictive value of resident memory CD8+T cell subpopulations in patients with non-small-cell lung cancer treated by immunotherapy
Paolini, Lea
Tran, Thi
Corgnac, Stephanie
Villemin, Jean-Philippe
Wislez, Marie
Arrondeau, Jennifer
Johannes, Ludger
Ulmer, Jonathan
Vieillard, Louis-Victorien
Pineau, Josephine
Gey, Alain
Quiniou, Valentin
Barennes, Pierre
Pham, Hang Phuong
Gruel, Nadege
Hasan, Milena
Libri, Valentina
Mella, Sebastien
De Percin, Sixtine
Boudou-Rouquette, Pascaline
Caidi, Aziza
Cremer, Isabelle
Blons, Helene
Leroy, Karen
Laurent-Puig, Pierre
De Saint Basile, Hortense
Gibault, Laure
Ravel, Patrice
Mami-Chouaib, Fathia
Goldwasser, Francois
Fabre, Elizabeth
Damotte, Diane
Tartour, Eric
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (12)
[26] TCF-1+ PD-1+ CD8+T cells are associated with the response to PD-1 blockade in non-small cell lung cancer patients
Xia Fang
Gang Wu
Jing Hua
Pei Zhao
Mengtian Shan
Na Wang
Yu Zeng
Tingting Ding
Hailong Zhu
Xuyou Zhu
Long Zhang
Yuting Liu
Ling Zheng
Xianghua Yi
Shaoyong Gao
Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2653 - 2660
[27] TCF-1+ PD-1+ CD8+T cells are associated with the response to PD-1 blockade in non-small cell lung cancer patients
Fang, Xia
Wu, Gang
Hua, Jing
Zhao, Pei
Shan, Mengtian
Wang, Na
Zeng, Yu
Ding, Tingting
Zhu, Hailong
Zhu, Xuyou
Zhang, Long
Liu, Yuting
Zheng, Ling
Yi, Xianghua
Gao, Shaoyong
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2653 - 2660
[28] CD8+T cell exhaustion and cancer immunotherapy
Wang, Qingda
Qin, Yang
Li, Bo
CANCER LETTERS, 2023, 559
[29] CD8+T cells infiltrating into tumors were controlled by immune status of pulmonary lymph nodes and correlated with non-small cell lung cancer (NSCLC) patients' prognosis treated with chemoimmunotherapy
Bai, Zhexin
Cheng, Xu
Ma, Tianyu
Li, Gege
Wang, Xiaojue
Wang, Ziyu
Yi, Ling
Liu, Zhidong
LUNG CANCER, 2024, 197
[30] The Utility of PD-L1/CD8 Dual Immunohistochemistry for Prediction of Response to Immunotherapy in Non-Small Cell Lung Cancer (NSCLC)
Rosenbaum, Matthew
Khosrowjerdi, Sara
Kem, Marina
Kamesan, Vashine
Digumarthy, Subba
Gainor, Justin
Mino-Kenudson, Mari
LABORATORY INVESTIGATION, 2019, 99

← 1 2 3 4 5 →